Implementation of Motor Function Measure score percentile curves - Predicting motor function loss in Duchenne muscular dystrophy.

Disease progression Duchenne Motor skills disorder Muscular dystrophy Neuromuscular diseases Reference values

Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 09 06 2021
revised: 10 11 2021
accepted: 12 11 2021
pubmed: 21 12 2021
medline: 19 1 2022
entrez: 20 12 2021
Statut: ppublish

Résumé

The Motor Function Measure is a standardized scoring system to evaluate motor function and monitor disease progression in neuromuscular diseases such as Duchenne muscular dystrophy. There are no available reference percentile curves for this measure. The aim of this analysis was to generate Motor Function Measure percentile curves for ambulant and non-ambulant patients affected by Duchenne Muscular Dystrophy, providing the opportunity to better evaluate the status and progression of an individual patient compared to other patients in the same age group. Data of patients aged between 6 and 15 years (819 measurements) was obtained from the international Motor Function Measure database. Age-dependent percentile curves were estimated using a "Generalized additive model for location, scale and shape" as suggested by the World Health Organisation Multicentre Growth Reference Study Group. Percentile curves for the Motor Function Measure total score and its sub-scores for patients with and without treatment with glucocorticoids are presented. Mean scores decline with age. Patients treated with glucocorticoids have higher mean values compared to glucocorticoid-naïve patients at the same age. The percentile curves with the online tool extend the clinical utility of the Motor Function Measure by facilitating the interpretation of individual standing and disease progression.

Identifiants

pubmed: 34929615
pii: S1090-3798(21)00197-5
doi: 10.1016/j.ejpn.2021.11.004
pii:
doi:

Substances chimiques

Glucocorticoids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-83

Investigateurs

Stéphanie Fontaine-Carbonnel (S)
Camille De Montferrand (C)
Sylvie Ragot-Mandry (S)
Stéphane Chabrier (S)
Manuella Fournier Mehouas (MF)
Hélène Rauscent (H)
Claude Cances (C)
François Rivier (F)
Jon Andoni Urtizberea (JA)
Sylviane Peudenier (S)
Sylvain Brochard (S)
Emmanuelle Lagrue (E)

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors state that they do not have any conflicts of interest to declare.

Auteurs

Patricia Hafner (P)

Division of Neuropediatrics, University of Basel Children's Hospital, Basel, Switzerland. Electronic address: patricia.hafner@ukbb.ch.

Simone Schmidt (S)

Division of Neuropediatrics, University of Basel Children's Hospital, Basel, Switzerland.

Sabine Schädelin (S)

Department of Clinical Research, Clinical Trial Unit, University of Basel Hospital, Basel, Switzerland.

Pascal Rippert (P)

Pôle Information Médicale, Évaluation, Recherche, Hospices Civils de Lyon, Lyon, France.

Dalil Hamroun (D)

CHRU de Montpellier, Direction de la Recherche et de l'Innovation, Hôpital La Colombière, Montpellier, France.

Solenn Fabien (S)

Division of Neuropediatrics, University of Basel Children's Hospital, Basel, Switzerland.

Bettina Henzi (B)

Division of Neuropediatrics, University of Basel Children's Hospital, Basel, Switzerland.

Niveditha Putananickal (N)

Division of Neuropediatrics, University of Basel Children's Hospital, Basel, Switzerland.

Daniela Rubino-Nacht (D)

Division of Neuropediatrics, University of Basel Children's Hospital, Basel, Switzerland.

Carole Vuillerot (C)

Département de Médecine Physique et de Réadaptation Pédiatrique, Hôpital Femme-mère-enfant, Hospices Civils de lyon, Bron, France; NeuroMyogene Institute, CNRS UMR 5310, INSERM U1217, Université de Lyon, Lyon, France.

Dirk Fischer (D)

Division of Neuropediatrics, University of Basel Children's Hospital, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH